Ipacare TZ 250mg/31.25mg Injection
Marketer
H & Care Incorp
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Ipacare TZ 250mg/31.25mg Injection
Cefixime and azithromycin injection, at a 250mg/31.25mg dose, combats bacterial infections by inhibiting microbial proliferation. This dual-antibiotic formulation requires administration by a healthcare provider. Complete the prescribed treatment regimen, regardless of symptom improvement. Missed doses should be avoided. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site reactions (redness, swelling, pain). Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Ipacare TZ 250mg/31.25mg Injection
The provided text is "undefined," so no rephrasing is possible.
Uses of Ipacare TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ipacare TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ipacare TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Ipacare TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Ipacare TZ 250mg/31.25mg Injection works:
Ipacare TZ Injection (250mg/31.25mg) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counters bacterial enzymes that would otherwise deactivate cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ipacare TZ 250mg/31.25mg Injection with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ipacare TZ (250mg/31.25mg) is typically deemed safe for use in pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ipacare TZ 250mg/31.25mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Following administration of Ipacare TZ 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until your vision has returned to normal.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ipacare TZ 250mg/31.25mg Injection. Dosage modification for Ipacare TZ 250mg/31.25mg Injection might be necessary. A physician's advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Ipacare TZ 250mg/31.25mg Injection in individuals with liver conditions is likely safe. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Ipacare TZ 250mg/31.25mg Injection :
Omit a dose of Ipacare TZ 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Ipacare TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently